Screen-detected breast cancers have a lower mitotic activity index (Q36621159)

15 August 2017

Screen-detected breast cancers have a lower mitotic activity index (English)

1 reference

15 August 2017

Groenendijk RP

1

1 reference

15 August 2017

Bult P

2

1 reference

15 August 2017

Tewarie L

3

1 reference

15 August 2017

Peer PG

4

1 reference

15 August 2017

van der Sluis RF

5

1 reference

15 August 2017

Ruers TJ

6

1 reference

15 August 2017

Wobbes T

7

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

82

1 reference

15 August 2017

2

1 reference

15 August 2017

381-384

1 reference

https://scigraph.springernature.com/pub.10.1054/bjoc.1999.0930

15 August 2017

0 references

cites work

Seventeen-year evaluation of breast cancer screening: the DOM project, The Netherlands. Diagnostisch Onderzoek (investigation) Mammacarcinoom

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Anticipating the consequences for the primary therapy of breast cancer after introducing screening. A more global picture for health care policy making

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

The relative prognostic significance of nucleolar morphometry in invasive ductal breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Mammographic screening in older women. Is it worthwhile?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Improving residents' performances of clinical breast examination.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Standardized mitotic counts in breast cancer. Evaluation of the method.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

The value of morphometry to classic prognosticators in breast cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Limited prognostic value of cellular DNA content to classical and morphometrical parameters in invasive ductal breast cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Mammographic screening: efficacy and guidelines.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients with morphometry, DNA flow cytometry and HER-2/neu oncoprotein expression. Preliminary results

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Regional differences in breast cancer survival are correlated with differences in differentiation and rate of proliferation

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

Breast-cancer mortality in a non-randomized trial on mammographic screening in women over age 65.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

'Blind' multicenter evaluation of the prognostic value of DNA image cytometric and morphometric features in invasive breast cancer.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363302

The Multi-Center Morphometric Mammary Carcinoma Project (MMMCP) in The Netherlands: value of morphometrically assessed proliferation and differentiation

20 September 2018

1 reference

12 December 2020

Predictive value of a morphometric prognostic index in female breast cancer

1 reference

12 December 2020

Age-specific sensitivities of mammographic screening for breast cancer

1 reference

12 December 2020

Interval carcinomas of the breast: a group with intermediate outcome

1 reference

12 December 2020

Breast cancer screening

1 reference

12 December 2020

Infiltrating lobular carcinoma of the breast detected by screening

1 reference

12 December 2020

Systematic ultrasonography in asymptomatic dense breasts

1 reference

12 December 2020

Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981

1 reference

12 December 2020

The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients

1 reference

12 December 2020

The Multicenter Morphometric Mammary Carcinoma Project (MMMCP). A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in The Netherlands

1 reference

12 December 2020

Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer

1 reference

12 December 2020

Syntactic structure analysis in invasive breast cancer: analysis of reproducibility, biologic background, and prognostic value

1 reference

12 December 2020

Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: classical and random mitotic activity assessments with correction for volume percentage of epithelium

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.1999.0930

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

1 reference